JP2024539132A5 - - Google Patents
Info
- Publication number
- JP2024539132A5 JP2024539132A5 JP2024523601A JP2024523601A JP2024539132A5 JP 2024539132 A5 JP2024539132 A5 JP 2024539132A5 JP 2024523601 A JP2024523601 A JP 2024523601A JP 2024523601 A JP2024523601 A JP 2024523601A JP 2024539132 A5 JP2024539132 A5 JP 2024539132A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- methyl
- groups
- optionally substituted
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2115156.8 | 2021-10-21 | ||
| GBGB2115156.8A GB202115156D0 (en) | 2021-10-21 | 2021-10-21 | Novel compounds |
| PCT/GB2022/052689 WO2023067355A1 (en) | 2021-10-21 | 2022-10-21 | Heterocyclic compounds for use in the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539132A JP2024539132A (ja) | 2024-10-28 |
| JP2024539132A5 true JP2024539132A5 (enExample) | 2026-04-07 |
Family
ID=78805918
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523601A Pending JP2024539132A (ja) | 2021-10-21 | 2022-10-21 | がんの治療における使用のためのヘテロ環式化合物 |
| JP2024523445A Pending JP2024542949A (ja) | 2021-10-21 | 2022-10-21 | がん治療での使用のためのヘテロ環式化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523445A Pending JP2024542949A (ja) | 2021-10-21 | 2022-10-21 | がん治療での使用のためのヘテロ環式化合物 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20240425511A1 (enExample) |
| EP (2) | EP4419527A1 (enExample) |
| JP (2) | JP2024539132A (enExample) |
| KR (1) | KR20240099274A (enExample) |
| CN (2) | CN119053600A (enExample) |
| AR (1) | AR127431A1 (enExample) |
| AU (1) | AU2022374050A1 (enExample) |
| CA (1) | CA3233255A1 (enExample) |
| DK (1) | DK4419526T3 (enExample) |
| ES (1) | ES3008687T3 (enExample) |
| FI (1) | FI4419526T3 (enExample) |
| GB (1) | GB202115156D0 (enExample) |
| HR (1) | HRP20250334T1 (enExample) |
| HU (1) | HUE070568T2 (enExample) |
| IL (1) | IL311922A (enExample) |
| LT (1) | LT4419526T (enExample) |
| MX (1) | MX2024004874A (enExample) |
| PL (1) | PL4419526T3 (enExample) |
| PT (1) | PT4419526T (enExample) |
| RS (1) | RS66620B1 (enExample) |
| SI (1) | SI4419526T1 (enExample) |
| SM (1) | SMT202500123T1 (enExample) |
| TW (1) | TW202334150A (enExample) |
| WO (2) | WO2023067356A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025077896A1 (zh) * | 2023-10-12 | 2025-04-17 | 上海湃隆生物科技有限公司 | 一种DNA聚合酶theta抑制剂及其应用 |
| CN118084767B (zh) * | 2024-04-02 | 2025-06-17 | 康龙化成手性医药技术(宁波)有限公司 | 一种外型-6-氟甲基-3-氮杂双环[3,1,0]己烷盐酸盐及其衍生物的合成方法 |
| WO2025214463A1 (zh) * | 2024-04-13 | 2025-10-16 | 正大天晴药业集团股份有限公司 | 含有三并环结构的化合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017062754A1 (en) | 2015-10-07 | 2017-04-13 | New York University | Compositions and methods for enhancing crispr activity by polq inhibition |
| EP4010080B1 (en) * | 2019-08-09 | 2023-09-27 | Artios Pharma Limited | Heterocyclic compounds for use in the treatment of cancer |
-
2021
- 2021-10-21 GB GBGB2115156.8A patent/GB202115156D0/en not_active Ceased
-
2022
- 2022-10-21 JP JP2024523601A patent/JP2024539132A/ja active Pending
- 2022-10-21 HR HRP20250334TT patent/HRP20250334T1/hr unknown
- 2022-10-21 DK DK22797829.3T patent/DK4419526T3/da active
- 2022-10-21 CN CN202280083817.2A patent/CN119053600A/zh active Pending
- 2022-10-21 IL IL311922A patent/IL311922A/en unknown
- 2022-10-21 US US18/699,286 patent/US20240425511A1/en active Pending
- 2022-10-21 HU HUE22797829A patent/HUE070568T2/hu unknown
- 2022-10-21 MX MX2024004874A patent/MX2024004874A/es unknown
- 2022-10-21 PT PT227978293T patent/PT4419526T/pt unknown
- 2022-10-21 CN CN202280070670.3A patent/CN118234728A/zh active Pending
- 2022-10-21 EP EP22802224.0A patent/EP4419527A1/en active Pending
- 2022-10-21 JP JP2024523445A patent/JP2024542949A/ja active Pending
- 2022-10-21 LT LTEPPCT/GB2022/052690T patent/LT4419526T/lt unknown
- 2022-10-21 KR KR1020247015701A patent/KR20240099274A/ko active Pending
- 2022-10-21 PL PL22797829.3T patent/PL4419526T3/pl unknown
- 2022-10-21 CA CA3233255A patent/CA3233255A1/en active Pending
- 2022-10-21 FI FIEP22797829.3T patent/FI4419526T3/fi active
- 2022-10-21 SI SI202230104T patent/SI4419526T1/sl unknown
- 2022-10-21 RS RS20250272A patent/RS66620B1/sr unknown
- 2022-10-21 WO PCT/GB2022/052690 patent/WO2023067356A1/en not_active Ceased
- 2022-10-21 ES ES22797829T patent/ES3008687T3/es active Active
- 2022-10-21 AR ARP220102871A patent/AR127431A1/es unknown
- 2022-10-21 SM SM20250123T patent/SMT202500123T1/it unknown
- 2022-10-21 WO PCT/GB2022/052689 patent/WO2023067355A1/en not_active Ceased
- 2022-10-21 US US18/701,963 patent/US20260124214A1/en active Pending
- 2022-10-21 TW TW111140009A patent/TW202334150A/zh unknown
- 2022-10-21 EP EP22797829.3A patent/EP4419526B1/en active Active
- 2022-10-21 AU AU2022374050A patent/AU2022374050A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5775070B2 (ja) | ヤヌスキナーゼ阻害剤としてのピラゾール−４−イル−ピロロ［２，３−ｄ］ピリミジンおよびピロール−３−イル−ピロロ［２，３−ｄ］ピリミジンのＮ−（ヘテロ）アリール−ピロリジン誘導体 | |
| AU2015296322B2 (en) | 2-amino-pyrido[2,3-d]pyrimidin-7(8h)-one derivatives as CDK inhibitors and uses thereof | |
| ES2985528T3 (es) | Nuevos compuestos y composiciones farmacéuticas de los mismos para el tratamiento de enfermedades | |
| CN105294683B (zh) | Cdk类小分子抑制剂的化合物及其用途 | |
| AU2015291522B2 (en) | Substituted urea derivatives and pharmaceutical uses thereof | |
| ES2871524T3 (es) | Pirrolo[2,3-d]pirimidinilo, pirrolo[2,3-b]pirazinilo y pirrolo[2,3-d]piridinil acrilamidas | |
| EP3755699A1 (en) | Shp2 phosphatase inhibitors and methods of use thereof | |
| JP2022548095A (ja) | 接着分解剤及びその使用方法 | |
| WO2025049641A1 (en) | Kras modulators and uses thereof | |
| ES2973661T3 (es) | Compuestos de cetona bicíclica y procedimientos de uso de los mismos | |
| CA3085937A1 (en) | Diazaindole compounds | |
| JP2019512505A5 (enExample) | ||
| WO2021074279A1 (en) | Spiro-fused tricyclic map4k1 inhibitors | |
| EP4041730B1 (en) | Substituted bicyclic heteroaryl compounds | |
| CN111867592A (zh) | 用于治疗异常细胞增殖的杂环化合物 | |
| EP3548484A1 (en) | Bicyclic amide compounds and methods of use thereof | |
| CA3050567A1 (en) | Substituted dihydroimidazopyridinediones as mknk1 and mknk2 inhibitors | |
| EP4051388A1 (en) | Substituted pyrazole compounds as toll receptor inhibitors | |
| WO2025194054A1 (en) | Spirocyclic compounds as modulators of kras and uses thereof | |
| JP2023517539A (ja) | Ｒｎａ結合タンパク質またはｒｎａ修飾タンパク質を標的とする化合物 | |
| WO2025194057A1 (en) | Macrocyclic compounds as modulators of kras and uses thereof | |
| ES2892624T3 (es) | Compuestos tricíclicos y composiciones como inhibidores de cinasas | |
| EP2721030A1 (en) | Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives | |
| TWI838644B (zh) | 芳甲醯取代的三環化合物及其製法和用途 | |
| WO2025240582A1 (en) | Macrocyclic compounds as modulators of kras and uses thereof |